Aesthetic Injectables Market - By Type {Botulinum Toxin, Dermal Fillers (Product [Hyaluronic Acid, Calcium Hydroxyapatite], Application (Face Lift, Wrinkle Reduction)}, Gender, Age Group, End-user & Forecast2024 – 2032

Aesthetic Injectables Market - By Type {Botulinum Toxin, Dermal Fillers (Product [Hyaluronic Acid, Calcium Hydroxyapatite], Application (Face Lift, Wrinkle Reduction)}, Gender, Age Group, End-user & Forecast2024 – 2032

Aesthetic Injectables Market Size

Aesthetic Injectables Market was valued at USD 13.2 billion in 2023 and is anticipated to showcase a growth of 10.2% to reach USD 31.3 billion by 2032. Aesthetic injectables refer to non-surgical cosmetic procedures that involve injecting substances into the skin to enhance or alter its appearance. These procedures are often performed for aesthetic purposes to address concerns such as wrinkles, fine lines, volume loss, and facial contouring among others.
 

The growth of the aesthetic injectables market is propelled by several factors, including the increasing aging population seeking non-surgical solutions for signs of aging, rising beauty consciousness across age groups, ongoing technological advancements for improving product safety and efficacy, and the minimally invasive nature of these procedures. According to International Society of Aesthetic Plastic Surgery, around 7.3 million non-surgical botulinum toxin procedures were performed. Thus, the growing awareness of aesthetic procedures and the availability of non-surgical options have contributed to an expanding patient base seeking injectable treatments.
 

Aesthetic Injectables Market Trends

• The global rise in the aging population, particularly in developed countries, has been a significant driver. As individuals age, they seek aesthetic solutions to address signs of aging, such as wrinkles, fine lines, and volume loss, contributing to the growing demand for aesthetic injectables.
   
• In addition, the non-surgical and minimally invasive nature of aesthetic injectables has gained more attention. Many individuals prefer these procedures over surgical options due to reduced risks, shorter recovery times, and the ability to achieve noticeable results without undergoing extensive surgery.
   
• Furthermore, innovations in the safety, efficacy, and longevity of aesthetic injectables enhance their appeal to both practitioners and patients. Ongoing advancements in technology, including improved product formulations and delivery systems contribute to the expansion of the market. The regulatory scrutiny, high cost of aesthetic procedure, and safety concerns can hamper the growth of aesthetic injectables industry.
   

Aesthetic Injectables Market Analysis

The market based on type, is categorized into botulinum toxin and dermal fillers. The botulinum toxin segment is expected to reach USD 16.8 billion by 2032. The botulinum toxin segment is further sub-categorized into botulinum toxin A and botulinum toxin B.
 

• Botulinum toxin has versatile applications in aesthetic medicine and commonly used to address dynamic wrinkles and fine lines by temporarily relaxing the muscles responsible for facial expressions. Also, the high effectiveness has contributed to its widespread adoption. For instance, Botox, as the most well-known brand in the market, has achieved widespread recognition and trust among both practitioners and patients. The brand’s long history, established safety profile, and extensive marketing efforts contributed to its dominant market position.
   

The aesthetic injectables market, by gender is segmented into female and male. In 2023, female segment accounted for 93.2%.
 

• The acceptance of aesthetic procedures has become more widespread, and women are usually more comfortable seeking enhancements. Also, aesthetic injectables, including dermal fillers and botulinum toxin, offer a range of applications beyond just anti-aging. Women may seek these treatments for purposes such as facial contouring, lip augmentation, and overall facial enhancement, contributing to the market growth.
   

By age group, the market is divided into 15 – 30, 31 – 40, 41 – 50, 51 – 60, >60. Among the age groups, 41 – 50 segment dominated the market and is expected to grow at CAGR of 10.5%.
 

• Growing application of aesthetic injectable to reduce signs of aging has driven the adoption rate in this age group segment. For instance, the age group populations between 41-50 years are prone to aging sings such as frown lines, crow’s feet, and forehead lines. According to the Aesthetic Society report 2020, more than 2 million females aged between 41-50 years underwent botulinum toxin surgery in 2020. The increasing number of botulinum toxin procedure to reduce such aging signs, will increase the product demand and spur the segmental growth.
   

The aesthetic injectables market, by end-user is classified into hospitals, dermatology clinics, and other end-users. The dermatology clinics segment dominated the market in 2023 and is expected to reach USD 15.3 billion by 2032.
 

• Factors like technological advancements, increasing disposable income, and a growing aging population contribute to this growth. Consumers seek safe and effective solutions for skin rejuvenation, driving clinics to offer a range of aesthetic injectables.
   
• The high patient preference for dermatology clinical and the state-of-art facility to enhance their aesthetic appearance is significantly contributing to the segmental growth.
   
• Also, various treatments such as cervical dystonia, wrinkles reduction, and acne scars among others is expected to increase the demand for minimally invasive treatment that are being performed in dermatology clinics, thereby fostering the industry growth. Additionally, a shift towards personalized beauty treatments amplifies the appeal of dermatology clinics in the flourishing aesthetic injectables landscape.
   

North America market accounted for USD 7.5 billion revenue in 2023 and is projected to reach USD 16.5 billion over the analysis timeline.
 

• The region boasts of a well-established and advanced healthcare infrastructure, including numerous dermatology clinics, medical spas, and aesthetic centers. The accessibility of such facilities contributes to the widespread availability of aesthetic injectables.
   
• In addition to this, the region is at the forefront of technological advancements in the medical and aesthetic fields. The region often witnesses early adoption of new products, formulations, and treatment techniques, contributing to the continuous growth of the aesthetic injectables industry.
   

Aesthetic Injectables Market Share

The aesthetic injectables industry is dynamic and competitive, driven by a combination of innovation, strategic collaborations, global expansion efforts, and a commitment to regulatory compliance. Companies such as Allergan (now part of AbbVie), Galderma, and Merz Pharma are notable players, with well-established product portfolios that include popular dermal fillers and botulinum toxin products.
 

Aesthetic Injectables Market Companies

Prominent players operating in the aesthetic injectables industry include

• AbbVie Inc (Allergan Plc.)
• Bio-Med Private Limited
• Bioxis Pharmaceuticals
• Cytophil, Inc.
• Galderma S.A.
• Ipsen SA
• Laboratories Vivacy SAS
• Merz Pharma GmbH & Co. KGaA.
• Mesoestetic
• Sinclair Pharma (Huadong Medicine Co., Ltd)
• Suneva Medical, Inc
• Teoxane Laboratories
   

Aesthetic Injectables Industry News

• In June 2023, Restylane Eyelight of Galderma received approval from U.S. FDA for its hyaluronic acid filler. The approval is expected to help the company to expand its product portfolio and revenue generated from its sales.
   
• In August 2022, Allergen Aesthetics launched Juvéderm VOLUX in India under its business unit of Allergan Aesthetics. This strategic initiative helped the company to broaden its customer base and outreach to untapped economies.
   

The aesthetic injectables market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments

Click here to Buy Section of this Report

Market, By Type

• Botulinum toxin
  • Botulinum toxin A
  • Botulinum toxin B
• Dermal fillers
  • By product type
    • Hyaluronic acid
    • Calcium hydroxyapatite
    • Poly-L-lactic acid
    • Polymethyl-methacrylate microspheres (PMMA)
    • Collagen
    • Fat fillers
    • Other dermal fillers
  • By application
    • Face lift
    • Facial correction
    • Wrinkles reduction
    • Acne scar
    • Lipoatrophy
    • Lip enhancement
    • Hip augmentation
    • Breast enhancement
    • Hand rejuvenation
    • Penis enlargement
    • Blepharoplasty
    • Neck & chin lift
    • Other applications

Market, By Gender

• Female
• Male

Market, By Age Group

• 15 – 30
• 31 – 40
• 41 – 50
• 51 – 60
• >60

Market, By End-user

• Hospitals
• Dermatology clinics
• Other end-users

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East and Africa